We might have an update for CHECKvacc in October. The numbers are only small (9) but it will be good to see how it went; especially considering the patient that went off treatment but subsequently had a complete response after being given a subsequent treatment that would not be expected to have that kind of response (implying the response was likely due to CHECKvacc but due to pseudoprogression, the patient was likely of the belief CHECKvacc wasn't working and changed to another treatment).
IMU Price at posting:
5.2¢ Sentiment: Buy Disclosure: Held
